Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-Reference-Cited by-同舟云学术

Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

Published:2015-02 Issue:2 Volume:169 Page:257-265.e1
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Hall Trygve Sørdahl,Hallén Jonas,Krucoff Mitchell W.,Roe Matthew T.,Brennan Danielle M.,Agewall Stefan,Atar Dan,Lincoff A. Michael

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study;Wu;Heart,2008

2. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction;Hallen;Am J Cardiol,2009

3. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function;Steen;J Am Coll Cardiol,2006

4. Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention;Boden;Am J Cardiol,2013

5. Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction;Hallen;Heart,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and validation of a prediction model for nonrecovery of left ventricular ejection fraction in acute myocardial infarction patients combined with decreased left ventricular ejection fraction;Clinical Cardiology;2024-01-29

2. Application of AMR in evaluating microvascular dysfunction after ST‐elevation myocardial infarction;Clinical Cardiology;2023-11-24

3. Application of AMR in evaluating microvascular dysfunction after ST-segment elevation myocardial infarction;2023-05-14

4. Comparison between the Levels of N Terminal Pro-Brain Natriuretic Peptide and Troponin I to Predict Left Ventricular Ejection Fraction in Patients Presenting with First ST-Elevation Myocardial Infarction;Pakistan Heart Journal;2023-04-01

5. Saudi Heart Association Position Statement on the Use of Biomarkers for the Management of Heart Failure and Acute Coronary Syndrome;Journal of the Saudi Heart Association;2022-08-10